Amicus Therapeutics (FOLD) Earnings Date, Estimates & Call Transcripts → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free FOLD Stock Alerts $9.57 +0.07 (+0.74%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (May. 9) -$0.02 Beat By $0.04 Consensus EPS (May. 9) -$0.06 Read Call TranscriptListen to Call Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueFOLD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FOLD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 Amicus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.07)($0.06)($0.06) Q2 20243($0.04)($0.01)($0.02) Q3 20243$0.01$0.03$0.02 Q4 20243$0.03$0.08$0.05 FY 202412($0.07)$0.04($0.02) Q1 20251$0.03$0.03$0.03 Q2 20251$0.06$0.06$0.06 Q3 20251$0.08$0.08$0.08 Q4 20251$0.09$0.09$0.09 FY 20254$0.26$0.26 $0.26FOLD Earnings Date and InformationAmicus Therapeutics last posted its earnings results on May 9th, 2024. The biopharmaceutical company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.04. The business earned $110.40 million during the quarter, compared to analyst estimates of $111.19 million. Its revenue was up 27.9% compared to the same quarter last year. Amicus Therapeutics has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for Amicus Therapeutics are expected to grow in the coming year, from ($0.19) to $0.22 per share. Amicus Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off prior year's report dates.Read More Amicus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 5/9/2024Q1 2024($0.06)($0.02)+$0.04$0.12$111.19 million$110.40 million 2/28/2024Q4 2023($0.06)($0.11)($0.05)($0.11)$115.11 million$115.08 million11/8/2023Q3 2023($0.08)($0.07)+$0.01($0.07)$102.30 million$103.50 million 8/8/2023Q2 2023($0.12)($0.15)($0.03)($0.15)$89.57 million$94.50 million5/10/2023Q1 2023($0.13)($0.18)($0.05)($0.18)$82.14 million$86.27 million3/1/2023Q4 2022($0.13)($0.19)($0.06)($0.19)$86.95 million$88.20 millionNext President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________.11/7/2022Q3 2022($0.19)($0.12)+$0.07($0.12)$84.55 million$81.69 million8/4/2022Q2 2022($0.23)($0.21)+$0.02($0.21)$85.12 million$80.73 million 5/9/2022Q1 2022($0.24)($0.30)($0.06)($0.30)$76.97 million$78.72 million 2/24/2022Q4 2021($0.14)($0.29)($0.15)($0.29)$82.57 million$82.15 million 11/8/2021Q3 2021($0.18)($0.19)($0.01)($0.19)$81.42 million$79.55 million 8/4/2021Q2 2021($0.22)($0.19)+$0.03($0.19)$71.35 million$77.41 million Amicus Therapeutics Earnings - Frequently Asked Questions When is Amicus Therapeutics's earnings date? Amicus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 13th, 2024 based off last year's report dates. Learn more on FOLD's earnings history. Did Amicus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Amicus Therapeutics (NASDAQ:FOLD) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.04. Learn more on analysts' earnings estimate vs. FOLD's actual earnings. How can I listen to Amicus Therapeutics's earnings conference call? The conference call for Amicus Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Amicus Therapeutics's conference call transcript? The conference call transcript for Amicus Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Amicus Therapeutics generate each year? Amicus Therapeutics (NASDAQ:FOLD) has a recorded annual revenue of $399.36 million. How much profit does Amicus Therapeutics generate each year? Amicus Therapeutics (NASDAQ:FOLD) has a recorded net income of -$151.58 million. FOLD has generated -$0.49 earnings per share over the last four quarters. What is Amicus Therapeutics's EPS forecast for next year? Amicus Therapeutics's earnings are expected to grow from ($0.19) per share to $0.22 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Geron Earnings Date Alkermes Earnings Date Perrigo Earnings Date Dynavax Technologies Earnings Date Madrigal Pharmaceuticals Earnings Date Ligand Pharmaceuticals Earnings Date Ironwood Pharmaceuticals Earnings Date MannKind Earnings Date Innoviva Earnings Date BridgeBio Pharma Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:FOLD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
